Wei Xu
Clinical trials sponsored by Wei Xu, explained in plain language.
-
Can an immune booster outsmart brain lymphoma?
Disease control Not yet recruitingThis trial is testing whether adding an immunotherapy drug called penpulimab to a standard chemotherapy regimen can help people with primary central nervous system lymphoma, a rare type of brain cancer. Participants, who have not yet received treatment, are randomly assigned to r…
Phase: NA • Sponsor: WEI XU • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New combo shows promise for rare blood cancer
Disease control Not yet recruitingThis study tests whether adding the drug golidocitinib to standard chemotherapy and immunotherapy works better than the standard treatment alone for people with advanced NK/T-cell lymphoma, a rare blood cancer. About 40 adults will be randomly assigned to one of two groups. The m…
Phase: PHASE2 • Sponsor: WEI XU • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC